DrugDashboards

Lidocaine Hydrochloride

Lidocaine Hydrochloride · LIDOCAINE HYDROCHLORIDE 20 mg/mL · Injection, Solution · Epidural; Infiltration; Intracaudal; Perineural · Hospira, Inc.

NDC 00409-2066-05 · 10 VIAL, SINGLE-DOSE in 1 CARTON / 5 mL in 1 VIAL, SINGLE-DOSE · ANDA · View full market →

The short version

18 companies supply this market — deep enough that no single failure threatens the supply. The price is down 13% over the past year, to $0.3487 per mL. It is in shortage right now — FDA lists the reason as “demand increase for the drug. Put together: worth watching — several of the pressures that precede supply trouble are present at once.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$0.2$0.4$0.6Sep 2022Sep 2026$0.3487
15 price points · per ML · held since Invalid DateSource: CMS NADAC

Estimated fill cost

WAC per package, as filed
$27.36
Reported to Texas DSHS · 2026 annual filing · Pfizer Inc.

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Medicaid spend (2025)

$43,415
12,471 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

43Elevated risk

The score is counting real pressure here. One of these alone is routine; it’s the combination that makes this market worth watching.

  • in shortage now+25
  • Class I/II recall on same molecule/form in past 12 months+8
  • sterile injectable+10

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.6%chance of a new FDA shortage posting for lidocaine hydrochloride (injectable) in the next 90 days

sterile injectable · 4 Class I/II recall(s) in 12 months · OAI inspection at a producing facility (24 months)

For scale: the typical drug’s chance is about 0.1% — this one is 4× that.

Backtested statistical model over the whole market, not this package alone. Model details →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
ANDA040078
TE code
AP
Approval date
Jun 23, 1995
Patents / exclusivity
None on file

Shortage history

  • In shortage now Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 0143-9577-10)Jun 13, 2018
    month 99 — 5× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months
  • In shortage now Lidocaine Hydrochloride, Injection, 10 mg/mL (NDC 55150-251-10)Jun 13, 2018
    Demand increase for the drug
    month 99 — 5× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months
  • In shortage now Lidocaine Hydrochloride, Injection, 10 mg/mL (NDC 55150-252-20)Jun 13, 2018
    month 99 — 5× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months
  • In shortage now Lidocaine Hydrochloride, Injection, 20 mg/1 mL (NDC 0143-9575-10)Jun 13, 2018
    month 99 — 5× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months
  • In shortage now Lidocaine Hydrochloride, Injection, 20 mg/mL (NDC 55150-254-10)Jun 13, 2018
    Demand increase for the drug
    month 99 — 5× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months
  • In shortage now Lidocaine Hydrochloride, Injection, 20 mg/mL (NDC 55150-255-20)Jun 13, 2018
    Demand increase for the drug
    month 99 — 5× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months
  • In shortage now Lidocaine Hydrochloride, Injection, 20 mg/mL (NDC 55150-256-50)Jun 13, 2018
    Demand increase for the drug
    month 99 — 5× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months
  • In shortage now Lidocaine Hydrochloride, Preservative Free, Injection, 10 mg/1 mL (NDC 0143-9595-25)Jun 13, 2018
    month 99 — 5× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months
  • In shortage now Lidocaine Hydrochloride, Preservative Free, Injection, 20 mg/1 mL (NDC 0143-9594-25)Jun 13, 2018
    month 99 — 5× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months
  • In shortage now Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 55150-159-74)Feb 20, 2018
    Demand increase for the drug
    month 103 — 5× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months
  • In shortage now Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 55150-161-02)Feb 20, 2018
    month 103 — 5× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months
  • In shortage now Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 55150-162-05)Feb 20, 2018
    month 103 — 5× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months
  • In shortage now Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 55150-163-30)Feb 20, 2018
    month 103 — 5× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months
  • In shortage now Lidocaine Hydrochloride, Injection, 20 mg/1 mL (NDC 55150-165-05)Feb 20, 2018
    month 103 — 5× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months
  • In shortage now Lidocaine Hydrochloride, Injection, 20 mg/mL (NDC 55150-164-02)Feb 20, 2018
    month 103 — 5× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months
  • In shortage now Lidocaine Hydrochloride And Dextrose, Injection, 4 mg/1 mL (NDC 0338-0409-03)Oct 25, 2017
    month 107 — 5× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months
  • In shortage now Lidocaine Hydrochloride And Dextrose, Injection, 8 mg/1 mL (NDC 0338-0411-02)Oct 25, 2017
    month 107 — 5× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months
  • In shortage now Xylocaine, Injection, .005 mg/1 mL; 10 mg/1 mL (NDC 63323-487-17)Oct 14, 2016
    month 119 — 6× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months
  • In shortage now Xylocaine, Injection, .005 mg/1 mL; 10 mg/1 mL (NDC 63323-487-37)Oct 14, 2016
    month 119 — 6× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months
  • In shortage now Lidocaine Hydochloride, Injection, 50 mg/5 mL (NDC 83634-653-05)Feb 22, 2012
    month 175 — 9× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months

Recalls (this NDC)

  • Class I · TerminatedJul 29, 2014
    Hospira Inc.Presence of Particulate Matter: The product was discolored and contained visible particulates (iron oxide) in the solution and embedded in the glass vial.
  • Class I · TerminatedDec 23, 2013
    Hospira Inc.Presence of Particulate Matter- Confimed customer complaint of particulates embedded in glass container and in contact with product solution.

Manufacturers of Lidocaine Hydrochloride (Injection, Solution)

LabelerStrengthFirst seenLast seen
Anthea Pharma Private LimitedLIDOCAINE HYDROCHLORIDE 20 mg/mLJul 15, 2026Sep 3, 2026
Asclemed USA, Inc.LIDOCAINE HYDROCHLORIDE 20 mg/mLJul 15, 2026Sep 3, 2026
Asclemed USA, Inc.LIDOCAINE HYDROCHLORIDE 10 mg/mLJul 15, 2026Sep 3, 2026
Camber Pharmaceuticals, Inc.LIDOCAINE HYDROCHLORIDE ANHYDROUS 10 mg/mLJul 15, 2026Sep 3, 2026
Eugia US LLCLIDOCAINE HYDROCHLORIDE 10 mg/mLJul 15, 2026Sep 3, 2026
Eugia US LLCLIDOCAINE HYDROCHLORIDE 20 mg/mLJul 15, 2026Sep 3, 2026
Fresenius Kabi USA, LLCLIDOCAINE HYDROCHLORIDE 20 mg/mLJul 15, 2026Sep 3, 2026
Fresenius Kabi USA, LLCLIDOCAINE HYDROCHLORIDE ANHYDROUS 5 mg/mLJul 15, 2026Sep 3, 2026
Fresenius Kabi USA, LLCLIDOCAINE HYDROCHLORIDE ANHYDROUS 20 mg/mLJul 15, 2026Sep 3, 2026
Fresenius Kabi USA, LLCLIDOCAINE HYDROCHLORIDE ANHYDROUS 10 mg/mLJul 15, 2026Sep 3, 2026
Henry Schein, Inc.LIDOCAINE HYDROCHLORIDE ANHYDROUS 10 mg/mLJul 15, 2026Sep 3, 2026
Henry Schein, Inc.LIDOCAINE HYDROCHLORIDE 20 mg/mLJul 15, 2026Sep 3, 2026
Hikma Pharmaceuticals USA Inc.LIDOCAINE HYDROCHLORIDE 20 mg/mLJul 15, 2026Sep 3, 2026
Hospira, Inc.LIDOCAINE HYDROCHLORIDE 10 mg/mLJul 15, 2026Sep 3, 2026
Hospira, Inc.LIDOCAINE HYDROCHLORIDE 5 mg/mLJul 15, 2026Sep 3, 2026
Hospira, Inc.LIDOCAINE HYDROCHLORIDE 20 mg/mLJul 15, 2026Sep 3, 2026
Lifestar Pharma LLCLIDOCAINE HYDROCHLORIDE 10 mg/mLJul 15, 2026Sep 3, 2026
Lifestar Pharma LLCLIDOCAINE HYDROCHLORIDE 20 mg/mLJul 15, 2026Sep 3, 2026
Medical Purchasing Solutions, LLCLIDOCAINE HYDROCHLORIDE 10 mg/mLJul 15, 2026Sep 3, 2026
Medical Purchasing Solutions, LLCLIDOCAINE HYDROCHLORIDE 20 mg/mLJul 15, 2026Sep 3, 2026
NorthStar RxLLCLIDOCAINE HYDROCHLORIDE ANHYDROUS 20 mg/mLJul 15, 2026Sep 3, 2026
NorthStar RxLLCLIDOCAINE HYDROCHLORIDE 20 mg/mLJul 15, 2026Sep 3, 2026
ProPharma DistributionLIDOCAINE HYDROCHLORIDE 20 mg/mLJul 15, 2026Sep 3, 2026
Sandoz Inc.LIDOCAINE HYDROCHLORIDE 10 mg/mLSep 3, 2026Sep 3, 2026
Sandoz Inc.LIDOCAINE HYDROCHLORIDE 20 mg/mLSep 3, 2026Sep 3, 2026
Sportpharm LLCLIDOCAINE HYDROCHLORIDE 10 mg/mLJul 15, 2026Sep 3, 2026
A-S Medication SolutionsLIDOCAINE HYDROCHLORIDE 10 mg/mLJul 15, 2026Sep 2, 2026
A-S Medication SolutionsLIDOCAINE HYDROCHLORIDE 20 mg/mLJul 15, 2026Sep 2, 2026
Anthea Pharma Private LimitedLIDOCAINE HYDROCHLORIDE 10 mg/mLJul 15, 2026Sep 2, 2026
Asclemed USA, Inc.LIDOCAINE HYDROCHLORIDE ANHYDROUS 20 mg/mLJul 15, 2026Sep 2, 2026
Baxter Healthcare CorporationLIDOCAINE HYDROCHLORIDE 8 mg/mLJul 15, 2026Sep 2, 2026
Baxter Healthcare CorporationLIDOCAINE HYDROCHLORIDE 4 mg/mLJul 15, 2026Sep 2, 2026
Cardinal Health 107, LLCLIDOCAINE HYDROCHLORIDE 20 mg/mLJul 15, 2026Sep 2, 2026
Cardinal Health 107, LLCLIDOCAINE HYDROCHLORIDE 10 mg/mLJul 15, 2026Sep 2, 2026
Civica, Inc.LIDOCAINE HYDROCHLORIDE 10 mg/mLJul 15, 2026Sep 2, 2026
Civica, Inc.LIDOCAINE HYDROCHLORIDE 20 mg/mLJul 15, 2026Sep 2, 2026
Fresenius Kabi USA, LLCLIDOCAINE HYDROCHLORIDE ANHYDROUS 15 mg/mLJul 15, 2026Sep 2, 2026
Fresenius Kabi USA, LLCLIDOCAINE HYDROCHLORIDE 10 mg/mLJul 15, 2026Sep 2, 2026
Fresenius Kabi USA, LLCLIDOCAINE HYDROCHLORIDE ANHYDROUS 10 mg/mL; EPINEPHRINE BITARTRATE .005 mg/mLAug 26, 2026Sep 2, 2026
Henry Schein, Inc.LIDOCAINE HYDROCHLORIDE 10 mg/mLJul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Lidocaine Hydrochloride — NDC 00409-2066-05," retrieved September 3, 2026, https://drugdashboards.com/drug/00409206605.

Free to cite with attribution — see how the data is put together.